Sildenafil Tablet
Product Images NDC 42291-937

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 42291-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

90 (937 90)

FDA Label Image

4 (Sildenafil Tablets 1)

FDA Label Image

1 (Sildenafil Tablets 2)

This text provides recommendations for drug interactions with Atorvastatin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. It includes information on dose adjustments and coadministration suggestions for these drugs. The text also notes specific interactions with Sildenafil, highlighting situations where coadministration did not show benefits in exercise capacity.*

FDA Label Image

1 (Sildenafil Tablets 3)

This text provides information on drug interactions and recommendations for dose adjustments based on fold changes and confidence intervals. It includes details on various drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. The text also mentions the impact of sildenafil and ritonavir on drug interactions.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 4)

FDA Label Image

10.1 (Sildenafil Tablets 5)

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.